News from sphere fluidics limited

Jun 24, 2014, 06:00 ET
The Cyto-Mine[TM] system is an integrated single cell analysis and monoclonality assurance device being developed by Sphere Fluidics Limited for the biopharmaceutical market. The machine uses novel microfluidics, nl-pl compartments (called picodroplets) and state-of-the-art optics and automation to perform up to one million single cell, cell-molecule or cell-cell assays per day. It will revolutionise bipharmaceutical discovery and development.

Sphere Fluidics Wins New Investment for Development of Unique, Single Cell Analysis Instrument

  Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization, and provides proprietary products...

Dec 10, 2013, 07:00 ET
Sphere Fluidics Logo

Sphere Fluidics: Expanding Executive Team for Growth of New Market Opportunity

Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel...

Jun 06, 2013, 12:33 ET
Dr Rob Marchmont

Sphere Fluidics: beschleunigtes Wachstum, um die Ausnahme zu finden!

Sphere Fluidtechnik Limited hat eine einzigartige Technologie für die Einzelzell-Analyse und -Auswertung entwickelt und bietet eigene...

Jun 06, 2013, 12:25 ET
Dr Rob Marchmont

Sphere Fluidics : accélérer la croissance pour trouver le « un sur un milliard » !

Sphere Fluidics Limited a développé une technologie unique pour l'analyse et la caractérisation de la cellule unique et propose...

Jun 06, 2013, 10:19 ET
Dr Rob Marchmont

Sphere Fluidics: Aumentar el crecimiento para encontrar el "uno entre mil millones"

Sphere Fluidics Limited ha desarrollado una tecnología única para el análisis y la caracterización de célula única...

Jun 06, 2013, 01:00 ET
Dr Rob Marchmont

Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"!

Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel...

Feb 20, 2013, 11:59 ET

Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round

Sphere Fluidics, an early-stage, Cambridge-based company focusing on developing novel products and services for single cell analysis, has just...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer